The similarities in the expression profile of TRPM4 and AR in DCIS, breast and prostate cancers suggest a connection of TRPM4 with AR signaling pathway in tumors, and this warrants future investigations. This evidence concerns the gene TRPM4 and ductal breast carcinoma in situ.